Bionure

Bionure

Bionure

Biotech company developing novel compounds in orphan ophthalmology. Neuroprotection and Remyelination. Optic Neuritis. Neuromyelitis Optica. Multiple Sclerosis.
Founded
2009
Raised
$1.1M
Follow us
Alexa global traffic share
Twitter followers
21 Mar 2017
€1,070,000
Equity crowdfunding

Bionure breaks the records raising more than €1M

Capital Cell
+1